What is GLUE's current stock price?

As of now, GLUE is trading at $24.18, with a daily change of -4.46%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

GLUE Stock Analysis & IQ Rating | Monte Rosa Therapeut

GLUE GLUE Badge

Monte Rosa Therapeut

$24.18

-$1.13 | -4.46%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

alert Latest Updates

StocksRunner Yesterday at 02:26

JPMorgan reset expectations for Alcoa after a strong rally, lowering its price target to about $44 while shares trade near $61. With aluminum pricing showing signs of leveling out and RSI above 70, analysts are signaling val...

BQ Stock IQ

Login to see Monte Rosa Therapeut (GLUE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

GLUE Target Price

Login to display

Strengths

GLUE Rewards

Upgraded on attractively valued

GLUE Rewards

Earnings are forecast to grow

GLUE Price Performance

$16.56 (+46.01%)

$10.61 (+127.90%)

$4.56 (+430.26%)

$5.75 (+320.52%)

1year

6month

3month

1month

GLUE Risk Level

GLUE has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

High volatilty

Extreme

LOW

HIGH

GLUE Analysts Opinion

GLUE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

GLUE Analysts Opinion

GLUE Analysts opinion is positive and also has improved from the past 3 months

GLUE Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

86%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

67%

GLUE Street Sentiment

GLUE Street Sentiment is extremely bullish and have positive views on the near-term outlook

GLUE Performance Sentiment

Sentiments overview associated with GLUE events and the stock performance.

86%

10%

Positive

Negative

25 out of 29
events present

3 out of 29
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$23.28

Resistance
Price

$14.40

Current Price Range

$23.12

Show methods +

GLUE Latest Analysis +

Monte Rosa Therapeutics announces pricing of $300M stock offering.

Today

$24.18 | -4.46%

Activity

Monte Rosa Therapeutics Prices Underwritten Public Offering Of $300 Mln Of Shares . (RTTNews) - Monte Rosa Therapeutics Inc. (GLUE) a developer of novel molecular glue degrader-based medicines said that it has priced its underwritten public offering of 11.125 million shares at $24 per share and in lieu of common stock to certain investors pre-funded warrant

Today

$24.18 | -4.46%

Activity

Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering. BOSTON Jan. 08 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics Inc. (Monte Rosa) (NASDAQ:) a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines today announced the pricing of an underwritten public offering of 11125000 shares of its common stock at a public offering price of $24.00 per share and in lieu of common stock to certain investors pre-funded warrants

Today

$24.18 | -4.46%

Activity

Monte Rosa Therapeutics (GLUE) is on the Move Heres Why the Trend Could be Sustainable . Monte Rosa Therapeutics (GLUE) made it through our Recent Price Strength screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Thu Jan 8, 2026

$25.31 | +8.72%

Potential

GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug. Monte Rosa shares surge 45% after interim phase I data show that MRT-8102 drives deep NEK7 degradation and reduces sharp inflammation markers.

Thu Jan 8, 2026

$25.31 | +8.72%

Activity

Momentum

Monte Rosa Therapeutics Reaches Analyst Target Price. In recent trading shares of Monte Rosa Therapeutics Inc (Symbol: GLUE) have crossed above the average analyst 12-month target price of $22.70 changing hands for $23.23/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: downg

Thu Jan 8, 2026

$25.31 | +8.72%

Potential

Monte Rosa Therapeutics launches $200M public equity offering.

Wed Jan 7, 2026

$23.28 | +45.35%

Activity

Monte Rosa Therapeutics (GLUE) Upgraded to Strong Buy: Heres Why. Monte Rosa Therapeutics (GLUE) has been upgraded to a Zacks Rank #1 (Strong Buy) reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.

Wed Jan 7, 2026

$23.28 | +45.35%

Momentum

Rating

Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants. BOSTON Jan. 07 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics Inc. (Monte Rosa) (NASDAQ:) a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines today announced that it has commenced an underwritten public offering of $200.0 million of shares of its common stock and in lieu of common stock to certain investors pre-funded warrants to purchase shares

Wed Jan 7, 2026

$23.28 | +45.35%

Activity

Monte Rosa surges on interim phase 1 data for MRT-8102 in inflammatory diseases.

Wed Jan 7, 2026

$23.28 | +45.35%

Momentum

FAQ About GLUE Stock Insights

What is GLUE current stock price?

What are GLUE stock strengths?

What is GLUE Risk Level?

What is GLUE market cap and volume?

What is GLUE current Stock IQ?

Should I buy GLUE stock right now?

Is GLUE a Strong Buy right now?

What does a 'Strong Buy' rating mean for GLUE?

What does a 'Strong Sell' rating mean for GLUE?

What factors influence GLUE's Stock IQ?

Explore our GLUE Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored GLUE Stock Strategies
Effective Risk Management

FIND US ON

Receive our GLUE Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

GLUE GLUE Badge

Monte Rosa Therapeut

Current Price

$24.18

-$1.13 | -4.46%

52W High

$25.77

MKT CAP

$1.57B

52W Low

$3.5

VOL

$4.59M

P/E Ratio

96.79

AVG VOL

$1.89M

RSI

70.94

TREND

Uptrend

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

GLUE Rewards

Upgraded on attractively valued

GLUE Rewards

Earnings are forecast to grow

GLUE Price Performance

$16.56 (+46.01%)

$10.61 (+127.90%)

$4.56 (+430.26%)

$5.75 (+320.52%)

1year

6month

3month

1month

GLUE Analysts Opinion

GLUE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

GLUE Analysts Opinion

GLUE Analysts opinion is positive and also has improved from the past 3 months

GLUE Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

86%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

67%

GLUE Street Sentiment

GLUE Street Sentiment is extremely bullish and have positive views on the near-term outlook

GLUE Risk Level

GLUE has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

High volatilty

Extreme

LOW

HIGH

GLUE Performance Sentiment

Sentiments overview associated with GLUE events and the stock performance.

86%

10%

Positive

Negative

25 out of 29
events present

3 out of 29
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$23.28

Resistance
Price

$14.40

Current Price Range

$23.12

Show methods +

GLUE Stock IQ

Login to unlock Monte Rosa Therapeut (GLUE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

GLUE Latest Analysis

StocksRunner Yesterday at 02:26

JPMorgan reset expectations for Alcoa after a strong rally, lowering its price target to about $44 while shares trade near $61. With aluminum pricing showing signs of leveling out and RSI above 70, analysts are signaling val...

Monte Rosa Therapeutics announces pricing of $300M stock offering.

Today

$24.18 | -4.46%

Activity

Monte Rosa Therapeutics Prices Underwritten Public Offering Of $300 Mln Of Shares . (RTTNews) - Monte Rosa Therapeutics Inc. (GLUE) a developer of novel molecular glue degrader-based medicines said that it has priced its underwritten public offering of 11.125 million shares at $24 per share and in lieu of common stock to certain investors pre-funded warrant

Today

$24.18 | -4.46%

Activity

Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering. BOSTON Jan. 08 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics Inc. (Monte Rosa) (NASDAQ:) a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines today announced the pricing of an underwritten public offering of 11125000 shares of its common stock at a public offering price of $24.00 per share and in lieu of common stock to certain investors pre-funded warrants

Today

$24.18 | -4.46%

Activity

Monte Rosa Therapeutics (GLUE) is on the Move Heres Why the Trend Could be Sustainable . Monte Rosa Therapeutics (GLUE) made it through our Recent Price Strength screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Thu Jan 8, 2026

$25.31 | +8.72%

Potential

GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug. Monte Rosa shares surge 45% after interim phase I data show that MRT-8102 drives deep NEK7 degradation and reduces sharp inflammation markers.

Thu Jan 8, 2026

$25.31 | +8.72%

Activity

Momentum

Monte Rosa Therapeutics Reaches Analyst Target Price. In recent trading shares of Monte Rosa Therapeutics Inc (Symbol: GLUE) have crossed above the average analyst 12-month target price of $22.70 changing hands for $23.23/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: downg

Thu Jan 8, 2026

$25.31 | +8.72%

Potential

Monte Rosa Therapeutics launches $200M public equity offering.

Wed Jan 7, 2026

$23.28 | +45.35%

Activity

Monte Rosa Therapeutics (GLUE) Upgraded to Strong Buy: Heres Why. Monte Rosa Therapeutics (GLUE) has been upgraded to a Zacks Rank #1 (Strong Buy) reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.

Wed Jan 7, 2026

$23.28 | +45.35%

Momentum

Rating

Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants. BOSTON Jan. 07 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics Inc. (Monte Rosa) (NASDAQ:) a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines today announced that it has commenced an underwritten public offering of $200.0 million of shares of its common stock and in lieu of common stock to certain investors pre-funded warrants to purchase shares

Wed Jan 7, 2026

$23.28 | +45.35%

Activity

Monte Rosa surges on interim phase 1 data for MRT-8102 in inflammatory diseases.

Wed Jan 7, 2026

$23.28 | +45.35%

Momentum

Discover GLUE Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of GLUE. We're here to help you make informed investment decisions today.

FIND US ON

Receive our GLUE Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

GLUE Stock trends

GLUE Stock performance

GLUE Stock analysis

GLUE investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing GLUE

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing GLUE

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

GLUE Stock Analysis & IQ Rating | Monte Rosa Therapeut

BQ Stock IQ

GLUE Target Price

GLUE Risk Level

GLUE Analysts Opinion

GLUE Street Sentiment

GLUE Performance Sentiment

Technical Price Levels

Explore our GLUE Stock insights

Receive our GLUE Daily Alerts

GLUE Street Sentiment

GLUE Risk Level

Technical Price Levels

Discover GLUE Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of GLUE. We're here to help you make informed investment decisions today.

Receive our GLUE Daily Alerts

GLUE Alerts